Login / Signup

Impact of intravenous thrombolysis on recanalization rates in patients with stroke treated with bridging therapy.

L MuellerF PultJ MeisterernstM R HeldnerM-L MonoR KurmannM BuehlmannU FischerH P MattleM ArnoldP MordasiniJ GrallaG SchrothM El-KoussySimon Jung
Published in: European journal of neurology (2017)
Relevant recanalization after IVT and prior to EVT in patients receiving bridging therapy was highly dependent on the occlusion site. These findings suggest that future randomized controlled trials should consider occlusion site and treatment paradigm to specify patients who benefit most from bridging therapy in comparison to EVT or IVT alone.
Keyphrases
  • randomized controlled trial
  • pulmonary embolism
  • stem cells
  • clinical trial
  • low dose
  • mesenchymal stem cells
  • brain injury
  • subarachnoid hemorrhage
  • blood brain barrier
  • combination therapy
  • cerebral ischemia